col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

53 Results       Page 1

American Chemical Society: ACS Central Science
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―17 Pseudo-Luciferase Activity of the SARS-CoV-2 Spike Protein for Cypridina Luciferin Ryo Nishihara, Hisham M. Dokainish, Yoshiki Kihara, Hiroki Ashiba, Yuji Sugita, Ryoji Kurita
2 [GO] 2023―Sep―21 Spike Protein Mutation-Induced Changes in the Kinetic and Thermodynamic Behavior of Its Receptor Binding Domains Explain Their Higher Propensity to Attain Open States in SARS-CoV-2 Variants of Concern Jasdeep Singh, Shubham Vashishtha, Bishwajit Kundu
3 [GO] 2023―Jul―25 Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir Yanmei Hu, Eric M. Lewandowski, Haozhou Tan, Xiaoming Zhang, Ryan T. Morgan, Xiujun Zhang, et al. (+7)
4 [GO] 2023―Jun―07 Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate Rui Su, Jin Zeng, Tara C. Marcink, Matteo Porotto, Anne Moscona, Ben O’Shaughnessy
5 [GO] 2023―May―10 Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2 Michael G. Wuo, Amanda E. Dugan, Melanie Halim, Blake M. Hauser, Jared Feldman, Timothy M. Caradonna, et al. (+10)
6 [GO] 2023―Apr―07 Development of a Manufacturing Process toward the Convergent Synthesis of the COVID-19 Antiviral Ensitrelvir Takahiro Kawajiri, Akihito Kijima, Atsuhiro Iimuro, Eisaku Ohashi, Katsuya Yamakawa, Kazushi Agura, et al. (+27)
7 [GO] 2023―Mar―21 SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu, Muhammad Bashir Khan, Wioletta Rut, Mikolaj Zmudzinski, et al. (+13)
8 [GO] 2023―Mar―20 Computational Protein Design for COVID-19 Research and Emerging Therapeutics Parismita Kalita, Timir Tripathi, Aditya K. Padhi
9 [GO] 2023―Feb―16 O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern Edgar Gonzalez-Rodriguez, Mia Zol-Hanlon, Ganka Bineva-Todd, Andrea Marchesi, Mark Skehel, Keira E. Mahoney, et al. (+16)
10 [GO] 2023―Feb―08 In Silico Discovery of Small Molecule Modulators Targeting the Achilles’ Heel of SARS-CoV-2 Spike Protein Qing Wang, Fanhao Meng, Yuting Xie, Wei Wang, Yumin Meng, Linjie Li, et al. (+6)
11 [GO] 2023―Jan―25 Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro Ningke Hou, Lei Shuai, Lijing Zhang, Xuping Xie, Kaiming Tang, Yunkai Zhu, et al. (+25)
12 [GO] 2023―Jan―13 A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress Response to Reactive Oxygen Species Cong Tang, Ana R. Coelho, Maria Rebelo, Hannah Kiely-Collins, Tânia Carvalho, Gonçalo J. L. Bernardes
13 [GO] 2023―Jan―02 Robust Covalent Aptamer Strategy Enables Sensitive Detection and Enhanced Inhibition of SARS-CoV-2 Proteins Dan Wang, Jing Zhang, Zhiyong huang, Yuhang Yang, Ting Fu, Yu Yang, et al. (+9)
14 [GO] 2022―Mar―29 Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction Scott E. Guimond, Courtney J. Mycroft-West, Neha S. Gandhi, Julia A. Tree, Thuy T. Le, C. Mirella Spalluto, et al. (+36)
15 [GO] 2022―Mar―23 How Early-Career Scientists Responded with Resiliency to the Space Created by the COVID-19 Pandemic Fun Man Fung, Safia Z. Jilani, Monica L. Ohnsorg, Rebecca L. Pinals, Mohit Saraf, Joshua Tropp, Peter Carlton
16 [GO] 2022―Feb―14 Mucins Inhibit Coronavirus Infection in a Glycan-Dependent Manner Casia L. Wardzala, Amanda M. Wood, David M. Belnap, Jessica R. Kramer
17 [GO] 2022―Feb―02 Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay Wenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, Namir Shaabani, Xinyu R. Ma, Erol C. Vatansever, et al. (+11)
18 [GO] 2021―Nov―22 Enzymatic Catalysts to Combat COVID-19 Isita Jhulki, Jordan L. Meier
19 [GO] 2021―Nov―04 Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses Victor Yin, Szu-Hsueh Lai, Tom G. Caniels, Philip J. M. Brouwer, Mitch Brinkkemper, Yoann Aldon, et al. (+6)
20 [GO] 2021―Oct―29 Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19 John A. McIntosh, Tamas Benkovics, Steven M. Silverman, Mark A. Huffman, Jongrock Kong, Peter E. Maligres, et al. (+15)
21 [GO] 2021―Sep―15 Nanopore Dwell Time Analysis Permits Sequencing and Conformational Assignment of Pseudouridine in SARS-CoV-2 Aaron M. Fleming, Nicole J. Mathewson, Shereen A. Howpay Manage, Cynthia J. Burrows
22 [GO] 2021―Jul―21 Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity Lisa R. Volpatti, Rachel P. Wallace, Shijie Cao, Michal M. Raczy, Ruyi Wang, Laura T. Gray, et al. (+24)
23 [GO] 2021―Jun―30 CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2 Razie Amraei, Wenqing Yin, Marc A. Napoleon, Ellen L. Suder, Jacob Berrigan, Qing Zhao, et al. (+12)
24 [GO] 2021―Jun―18 Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay Chunlong Ma, Michael Dominic Sacco, Zilei Xia, George Lambrinidis, Julia Alma Townsend, Yanmei Hu, et al. (+11)
25 [GO] 2021―Jun―18 An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory Ole A. W. Haabeth, Julian J. K. Lohmeyer, Adrienne Sallets, Timothy R. Blake, Idit Sagiv-Barfi, Debra K. Czerwinski, et al. (+5)
26 [GO] 2021―Jun―03 Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2 Lin Liu, Pradeep Chopra, Xiuru Li, Kim M. Bouwman, S. Mark Tompkins, Margreet A. Wolfert, et al. (+2)
27 [GO] 2021―May―27 Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display Alexander Norman, Charlotte Franck, Mary Christie, Paige M. E. Hawkins, Karishma Patel, Anneliese S. Ashhurst, et al. (+10)
28 [GO] 2021―Apr―19 Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines Yury Valdes-Balbin, Darielys Santana-Mederos, Françoise Paquet, Sonsire Fernandez, Yanet Climent, Fabrizio Chiodo, et al. (+10)
29 [GO] 2021―Apr―16 Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir Ho Sing Lo, Kenrie Pui Yan Hui, Hei-Ming Lai, Xu He, Khadija Shahed Khan, Simranjeet Kaur, et al. (+29)
30 [GO] 2021―Apr―06 Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines Kellie D. Nance, Jordan L. Meier
31 [GO] 2021―Apr―02 Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine Yasunori Watanabe, Luiza Mendonça, Elizabeth R. Allen, Andrew Howe, Mercede Lee, Joel D. Allen, et al. (+17)
32 [GO] 2021―Mar―31 Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike Juliane Brun, Snežana Vasiljevic, Bevin Gangadharan, Mario Hensen, Anu V. Chandran, Michelle L. Hill, et al. (+5)
33 [GO] 2021―Mar―29 A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, Cynthia Liu, Steven Watkins, Qiongqiong Zhou
34 [GO] 2021―Mar―24 Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19 Corleone S. Delaveris, Aaron J. Wilk, Nicholas M. Riley, Jessica C. Stark, Samuel S. Yang, Angela J. Rogers, et al. (+4)
35 [GO] 2021―Mar―03 Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines Stephen Pelly, Dennis Liotta
36 [GO] 2021―Feb―22 Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations Chun-Hui Zhang, Elizabeth A. Stone, Maya Deshmukh, Joseph A. Ippolito, Mohammad M. Ghahremanpour, Julian Tirado-Rives, et al. (+10)
37 [GO] 2021―Jan―15 Handheld Point-of-Care System for Rapid Detection of SARS-CoV-2 Extracted RNA in under 20 min Jesus Rodriguez-Manzano, Kenny Malpartida-Cardenas, Nicolas Moser, Ivana Pennisi, Matthew Cavuto, Luca Miglietta, et al. (+9)
38 [GO] 2021―Jan―15 Correction to “The SARS-COV-2 Spike Protein Binds Sialic Acids, and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device” Alexander Baker, Sarah-Jane Richards, Thomas Congdon, Muhammad Hasan, Collette Guy, Alexander Zwetsloot, et al. (+10)
39 [GO] 2021―Jan―08 Modeling the Binding Mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase Fabian Byléhn, Cintia A. Menéndez, Gustavo R. Perez-Lemus, Walter Alvarado, Juan J. de Pablo
40 [GO] 2021―Jan―06 A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, Shaogeng Tang, Payton A. Weidenbacher, Shanshan Li, et al. (+4)
41 [GO] 2020―Dec―18 De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein Sebastian Pomplun, Muhammad Jbara, Anthony J. Quartararo, Genwei Zhang, Joseph S. Brown, Yen-Chun Lee, et al. (+3)
42 [GO] 2020―Oct―21 SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution Hongye Wang, Xian Wu, Xiaomei Zhang, Xin Hou, Te Liang, Dan Wang, et al. (+6)
43 [GO] 2020―Oct―12 Fighting COVID-19 Using Molecular Dynamics Simulations Pablo R. Arantes, Aakash Saha, Giulia Palermo
44 [GO] 2020―Oct―02 New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA Audrey Di Giorgio, Maria Duca
45 [GO] 2020―Sep―30 Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders Hafeez S. Haniff, Yuquan Tong, Xiaohui Liu, Jonathan L. Chen, Blessy M. Suresh, Ryan J. Andrews, et al. (+5)
46 [GO] 2020―Sep―23 Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein Lorenzo Casalino, Zied Gaieb, Jory A. Goldsmith, Christy K. Hjorth, Abigail C. Dommer, Aoife M. Harbison, et al. (+6)
47 [GO] 2020―Sep―23 The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device Alexander N. Baker, Sarah-Jane Richards, Collette S. Guy, Thomas R. Congdon, Muhammad Hasan, Alexander J. Zwetsloot, et al. (+10)
48 [GO] 2020―Sep―11 COVID-19 Pandemic Has Spurred Materials Researchers to Develop Antiviral Masks Dinsa Sachan
49 [GO] 2020―Jul―21 Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine Ariel H. Thames, Kristy L. Wolniak, Samuel I. Stupp, Michael C. Jewett
50 [GO] 2020―Jun―16 Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19 Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D. Hall
51 [GO] 2020―May―04 Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D. Hall
52 [GO] 2020―Apr―30 Assay Techniques and Test Development for COVID-19 Diagnosis Linda J. Carter, Linda V. Garner, Jeffrey W. Smoot, Yingzhu Li, Qiongqiong Zhou, Catherine J. Saveson, et al. (+6)
53 [GO] 2020―Mar―12 Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases Cynthia Liu, Qiongqiong Zhou, Yingzhu Li, Linda V. Garner, Steve P. Watkins, Linda J. Carter, et al. (+5)

53 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec